Skip to content

Clinical trials

Myocardial Infarction trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Country / region: Singapore Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20061
20101
20111
20141
20152
20182
20191
20221
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting3
Terminated3
Active, not recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart Centre Singapore2
Sanofi2
AstraZeneca1
Boehringer Ingelheim1
CellProthera1
Maasstad Hospital1
Moleac Pte Ltd.1
National University Hospital, Singapore1
National University of Singapore1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction16
Acute Coronary Syndrome3
Cardiovascular Diseases3
Coronary Artery Disease3
Stroke3
Angina Pectoris1
Angina, Stable1
Angina, Unstable1
Chest Pain1
Coronary Stenosis1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.